Efficacy of Etamsylate Eye Drops in Wet-Age-Related Macular Degeneration: A Case Report

The principal cause of blindness is age-related macular degeneration which wet form represents 10% of cases. The first line therapy for wet macular degeneration is frequent intravitreal injections of anti-vascular endothelial growth factor which is associated with important secondary effects. We reported previously the efficacy and safety of a single intravitreal injection of etamsylate (a synthetic inhibitor of fibroblast growth factor and vascular endothelial growth factor) in macular degeneration. The present report shows the improvement of visual acuity and retinal anatomical patterns in a patient affected by wet macular degeneration, after 30 days of eye drops instillation.